2024-07-15 REPLIGEN CORP Cybersecurity Incident

Page last updated on August 21, 2024

REPLIGEN CORP initially disclosed a cybersecurity incident in an SEC 8-K filing on 2024-07-15 16:05:53 EDT.

Company Summary

Repligen is a biopharmaceutical company developing consumable products for the manufacture of biological drugs.

Incident Details

Material: Unknown
Is Breach: Unknown
Records Compromised: Unknown
Data Types Impacted: No Data Types Tracked (yet)

Compromised Date:
Detected Date: 2024-07-09
Disclosure Date: 2024-07-15
Contained Date: 2024-07-15
Recovered Date:

Attack Goal: Unknown

Costs: No Costs Tracked (yet)

Filings

8-K filed on 2024-07-15

REPLIGEN CORP filed an 8-K at 2024-07-15 16:05:53 EDT
Accession Number: 0001193125-24-179061

Item 8.01 Other Events.

On July 9, 2024, Repligen Corporation (the “Company”) discovered that an unauthorized third party had accessed certain files on the Company’s information systems. Upon this discovery, the Company immediately activated response procedures to investigate, contain, and remediate the incident and also notified law enforcement, in accordance with the Company’s established protocols. The Company has engaged external cybersecurity experts to assist with the investigation and other response activities. As of the date of this report, other than the Company’s response and remediation activities, the incident has not had an impact on the Company’s business or operations. The Company’s ability to serve customers has also not been impacted, and its information systems remain operational and undisrupted. Further, the Company does not anticipate that this incident will have a material impact on its financial condition or results of operations. While the Company believes it has contained the incident and that no systems were encrypted by malware, it continues to investigate this matter to determine the full extent of the impact on the Company, including what, if any, regulatory and legal notifications the Company will need to make as a result of this matter.


Company Information

NameREPLIGEN CORP
CIK0000730272
SIC DescriptionBiological Products, (No Diagnostic Substances)
TickerRGEN - Nasdaq
Website
CategoryLarge accelerated filer
Fiscal Year EndDecember 30